Abstract
In Reply. —Our critics assert that data from RCTs, especially when pooled, must be viewed cautiously, even skeptically, when making statements that bear directly on health policy. They are particularly critical about trials with a short time horizon and allude to study selection bias. All RCTs that met our stringent eligibility criteria were included in the primary analysis, and extensive subgroup analyses were performed and reported, although, because of editorial constraints, not in the detail that both we and Dr Stamler would have desired. Dr Whelton and colleagues and Drs Kotchen and Krauss chose to ignore the point made in our article that the inclusion of short-term trials amplified the effect of dietary salt restriction. For example, excluding the short-term trials in normotensive subjects (
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
